Pharmacology of inhibitors of parietal cell function.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002478:Cells, Cultured; D002927:Cimetidine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D004285:Dogs; D011464:Epoprostenol / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects*; D005755:Gastrins / Q000494:pharmacology; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007811:Lanthanum / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D011970:Receptors, Histamine H2 / Q000032:analysis / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects
D005755:Gastrins; D005765:Gastrointestinal Agents; D011458:Prostaglandins E; D011970:Receptors, Histamine H2; D011976:Receptors, Muscarinic; D003995:Dibutyryl Cyclic GMP; D007811:Lanthanum; D001285:Atropine; D002927:Cimetidine; D006632:Histamine; D011464:Epoprostenol; D000242:Cyclic AMP